Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Five months after BC's premier called for reforms to its costly rare disease drug program, no changes have been made, leaving patients without reliable access.
Five months after British Columbia’s premier called for reforms to its high-cost rare disease drug program, no concrete changes have been made.
The program, intended to provide life-saving treatments, continues to face delays, inconsistent approvals, and limited transparency.
Patients and advocates report ongoing struggles with access and affordability, despite some temporary solutions.
Health officials acknowledge challenges in balancing cost and care but have not announced a timeline for reforms, leaving families in uncertainty.
3 Articles
Cinco meses después de que el primer ministro de BC pidiera reformas a su costoso programa de medicamentos para enfermedades raras, no se han realizado cambios, dejando a los pacientes sin un acceso confiable.